Restore Medical to Present at C.E. Unterberg, Towbin Life Sciences Investor Conference
23 Outubro 2006 - 12:32PM
Business Wire
Restore Medical, Inc. (NASDAQ:REST), developer of the innovative
Pillar� Palatal Implant System � a simple, minimally-invasive
treatment for individuals suffering from snoring and
mild-to-moderate obstructive sleep apnea (OSA) � today announced
that Bob Paulson, Restore Medical�s President and CEO, will present
at the C.E. Unterberg, Towbin Life Sciences Conference on Tuesday,
October 31, 2006, at 9:30 AM Eastern Time. The conference will be
held at the Palace Hotel in New York City from October 30 through
October 31, 2006. Individuals may listen to a live web cast of the
presentation by logging on to the Investor Relations section of
Restore�s web site www.restoremedical.com a few minutes prior to
start time to download any necessary software. The C.E. Unterberg,
Towbin Life Sciences Conference will feature representatives from
95 emerging growth companies from biotechnology, medical
technology, drug delivery and specialty pharmaceuticals sectors.
About Restore Medical and the Pillar Procedure Restore Medical
develops, manufactures and markets innovative medical devices to
treat sleep-disordered breathing. The Company�s proprietary Pillar�
Palatal Implant System is the only implantable palatal device to
treat snoring and mild-to-moderate obstructive sleep apnea to be
approved by the U.S. Food and Drug Administration and Health
Canada, and to have received the CE Mark for sale in the European
Union. The Pillar Palatal Implant System is sold throughout the
U.S. and Canada, and in various countries in Asia Pacific, Europe,
South America and the Middle East. For more information about
Restore Medical, the Pillar Procedure and physicians who offer the
Pillar Procedure, visit the Company's website at
www.restoremedical.com or www.pillarprocedure.com. Restore Medical,
Inc. (NASDAQ:REST), developer of the innovative Pillar(R) Palatal
Implant System - a simple, minimally-invasive treatment for
individuals suffering from snoring and mild-to-moderate obstructive
sleep apnea (OSA) - today announced that Bob Paulson, Restore
Medical's President and CEO, will present at the C.E. Unterberg,
Towbin Life Sciences Conference on Tuesday, October 31, 2006, at
9:30 AM Eastern Time. The conference will be held at the Palace
Hotel in New York City from October 30 through October 31, 2006.
Individuals may listen to a live web cast of the presentation by
logging on to the Investor Relations section of Restore's web site
www.restoremedical.com a few minutes prior to start time to
download any necessary software. The C.E. Unterberg, Towbin Life
Sciences Conference will feature representatives from 95 emerging
growth companies from biotechnology, medical technology, drug
delivery and specialty pharmaceuticals sectors. About Restore
Medical and the Pillar Procedure Restore Medical develops,
manufactures and markets innovative medical devices to treat
sleep-disordered breathing. The Company's proprietary Pillar(R)
Palatal Implant System is the only implantable palatal device to
treat snoring and mild-to-moderate obstructive sleep apnea to be
approved by the U.S. Food and Drug Administration and Health
Canada, and to have received the CE Mark for sale in the European
Union. The Pillar Palatal Implant System is sold throughout the
U.S. and Canada, and in various countries in Asia Pacific, Europe,
South America and the Middle East. For more information about
Restore Medical, the Pillar Procedure and physicians who offer the
Pillar Procedure, visit the Company's website at
www.restoremedical.com or www.pillarprocedure.com.
Restore Medical (MM) (NASDAQ:REST)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Restore Medical (MM) (NASDAQ:REST)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Restore Medical (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Restore Medical, Inc.